We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Technique Boosts Chemotherapy and Radiation Effects

By HospiMedica staff writers
Posted on 01 Aug 2002
A new technique uses hyperthermia to boost the killing power of radiation and chemotherapy to treat cancer patients.

Based on the principle that raising the temperature of tissue induces greater blood flow in that tissue, the technique uses a focused microarray to target and heat cancerous tumors. More...
The resulting increased blood flow improves the transport of drugs into the tumor so that more chemotherapy drug reaches the tumor area. The increased blood flow also increases oxygen levels in tumors so that more cancer-destroying oxygen radicals can be formed during radiation treatments, making cells more susceptible to radiation.

Doctors at a new cancer center in the Charite Medical School of Humboldt University in Berlin (Germany) are using the new technique. They estimate that it doubles the amount of chemotherapy reaching the tumor. "If we heat up the tumor to 43- 44O C for a short time, the cells are directly destroyed. Then we profit from both effects: destruction by heat and intensification of chemotherapy and radiation,” said Dr. Peter Wurst. The doctors say the technique also destroys the cell nests bordering the tumor, which increases the possibility of complete resection of the tumor and consequent cure. Following treatment, they report that patients require little or no pain medication.

The system used at Charite focuses and delivers microwave energy and monitors the temperature and the blood circulation changes "online” using a magnetic resonance tomograph (NRT). The 3D microwave phased array system used in the new treatment was provided by BSD Medical Corp. (Salt Lake City, UT, USA), while the magnetic resonance equipment was provided by Siemens Medical Systems (Erlangen, Germany).




Related Links:
Humboldt U.
BSD Medical

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.